The substrate specificity of the pharmaceutically attractive tumor-promoter SIRT5 was already investigated multiple times by advanced proteomic tools. However, the present pathway enrichment and gene function prediction analysis bring new highlights to the overall knowledge about the lysine demalonylation activity of SIRT5, a member of the sirtuin family with many roles in aging and age-related diseases. It shows previously unreported aspects of the involvement of the lysine demalonylated SIRT5 substrates in Eukaryotic translation elongation (ETE), Amino acid and derivative metabolism (AADM), and Selenoamino acid metabolism (SAM). The cluster of the elongation factors (EEF1A1, EEF2, EEF1D, and EEF1G) belonging to ETE participates in the peptide chain elongation and the export of the tRNA-s from the nucleus the primary sites of the proteosynthesis. SIRT5 regulates key enzymes with tumor-promoting functions involved in AADM (GLUD1, SHMT1, ACAT1), which fits its experimentally proven tumor promoter functions. In contrast, SIRT5 also lysine demalonylates tumor suppressor substrates involved in AADM and SAM (ALDH9A1, BHMT, GNMT). It indicates comparable functions like directly interacting family member SIRT3, which was reported to have dual tumor promoter/oncogene functions. Similar to the roles of the sirtuins, the SAM pathway impacts longevity, protects against cardiovascular diseases, and is associated with hepatic steatosis. The selen supplementation also mediates the calorie restriction effect, which increases the NAD+/NADH ratio in the cells and stimulates the expression of SIRT5 and other sirtuins. SIRT5 in turn regulates the selenocysteine synthesis through the lysine demalonylation of the participating ribosomal proteins, SECISBP2 and GNMT, which creates a regulatory loop.